31 Over the past 20 years, new GLP-1RAs with extended half-lives have proven to be highly effective treatments for T2D and even weight loss
Congenital CMV infection causes serious neurodevelopmental sequelae, including mental retardation, cerebral palsy, and sensorineural hearing loss
Mol Metab (2014) 3(3):24151
[CrossRef] [Google Scholar] Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
GIP plays a role in managing blood sugar and energy balance
At the March committee meeting, Kinsley said the cost to the state for GLP-1 coverage would be "is in the range of zero to 10 million in state dollars, which is much cheaper than a lot of the costs of cardiovascular disease." According to the NCDHHS statement, which was issued to WUNC on Thursday, "...the current estimate to cover GLP-1s is approximately $16 million annually